Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1989 1
1991 1
1993 2
1994 2
1997 1
1998 1
2000 3
2001 3
2002 1
2003 4
2004 4
2005 4
2006 3
2007 3
2008 4
2009 8
2010 3
2011 2
2012 6
2013 9
2014 6
2015 10
2016 5
2017 9
2018 6
2019 14
2020 13
2021 4
2022 3
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

125 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Metastatic Lung Large Cell Neuroendocrine Carcinoma"
Page 1
Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group.
Mosele F, Remon J, Mateo J, Westphalen CB, Barlesi F, Lolkema MP, Normanno N, Scarpa A, Robson M, Meric-Bernstam F, Wagle N, Stenzinger A, Bonastre J, Bayle A, Michiels S, Bièche I, Rouleau E, Jezdic S, Douillard JY, Reis-Filho JS, Dienstmann R, André F. Mosele F, et al. Ann Oncol. 2020 Nov;31(11):1491-1505. doi: 10.1016/j.annonc.2020.07.014. Epub 2020 Aug 24. Ann Oncol. 2020. PMID: 32853681 Free article. Review.
Based on the current evidence, ESMO recommends routine use of NGS on tumour samples in advanced non-squamous non-small-cell lung cancer (NSCLC), prostate cancers, ovarian cancers and cholangiocarcinoma. ...In addition, based on the KN158 trial and considering that p …
Based on the current evidence, ESMO recommends routine use of NGS on tumour samples in advanced non-squamous non-small-cell lung …
Large cell neuroendocrine carcinoma arising from the anterior mediastinum.
Montebello A, Zahra Bianco E, Babic D, Delicata NP, Azzopardi N. Montebello A, et al. BMJ Case Rep. 2021 May 25;14(5):e240453. doi: 10.1136/bcr-2020-240453. BMJ Case Rep. 2021. PMID: 34035017 Free PMC article.
Anterior mediastinal large cell neuroendocrine carcinomas (LCNECs) are extremely rare, extremely aggressive malignancies that carry a dismal prognosis. ...The patient was planned to receive platinum/etoposide chemotherapy for a metastatic …
Anterior mediastinal large cell neuroendocrine carcinomas (LCNECs) are extremely rare, extremely aggressive mali …
Therapeutic options in lung neuroendocrine tumors: between established concepts and new hopes.
Brighi N, Lamberti G, Manuzzi L, Maggio I, Campana D. Brighi N, et al. Anticancer Drugs. 2019 Aug;30(7):e0784. doi: 10.1097/CAD.0000000000000784. Anticancer Drugs. 2019. PMID: 30896503 Review.
Typical (TC) and atypical (AC) carcinoids are low-grade neuroendocrine tumors (NETs) of the lung and, are neglected diseases in respect of both high-grade NETs of the lung (i.e. small-cell lung cancer and large-cell neuroendocri …
Typical (TC) and atypical (AC) carcinoids are low-grade neuroendocrine tumors (NETs) of the lung and, are neglected diseases i …
Metastatic non-small cell lung carcinoma a mimic of primary breast carcinoma-case series and literature review.
Ali RH, Taraboanta C, Mohammad T, Hayes MM, Ionescu DN. Ali RH, et al. Virchows Arch. 2018 May;472(5):771-777. doi: 10.1007/s00428-017-2262-4. Epub 2017 Nov 5. Virchows Arch. 2018. PMID: 29105026 Review.
Of these, non-mammary carcinomatous metastases to the breast are particularly challenging and, without a clinical history, may be extremely difficult to distinguish from primary breast carcinoma (PBC). We specifically studied metastatic tumors of pulmonary origin, a …
Of these, non-mammary carcinomatous metastases to the breast are particularly challenging and, without a clinical history, may be extremely …
Pulmonary large-cell neuroendocrine carcinoma (LCNEC).
Hage R, Seldenrijk K, de Bruin P, van Swieten H, van den Bosch J. Hage R, et al. Eur J Cardiothorac Surg. 2003 Apr;23(4):457-60. doi: 10.1016/s1010-7940(02)00837-0. Eur J Cardiothorac Surg. 2003. PMID: 12694759 Review.
OBJECTIVE: The experiences on the treatment of seven consecutive patients with large-cell neuroendocrine carcinoma (LCNEC) were studied, observed over 6 years from 1992. ...Together with the carcinoids (atypical and typical) and the small-cell …
OBJECTIVE: The experiences on the treatment of seven consecutive patients with large-cell neuroendocrine carcinoma …
Large Cell Neuroendocrine Carcinoma of the Prostate: A Systematic Review and Pooled Analysis.
Tu X, Chang T, Nie L, Qiu S, Xu H, Huang Y, Bao Y, Liu Z, Yang L, Wei Q. Tu X, et al. Urol Int. 2019;103(4):383-390. doi: 10.1159/000499883. Epub 2019 Apr 9. Urol Int. 2019. PMID: 30965328
BACKGROUND: Large cell neuroendocrine carcinoma (LCNEC) of the prostate is an extremely rare entity, and the clinicopathological course, potential effective treatment, and prognosis are yet to be elucidated. ...The other 3 patients were d …
BACKGROUND: Large cell neuroendocrine carcinoma (LCNEC) of the prostate is an extremely rare entity, and the cli …
Bronchopulmonary neuroendocrine tumors.
Gustafsson BI, Kidd M, Chan A, Malfertheiner MV, Modlin IM. Gustafsson BI, et al. Cancer. 2008 Jul 1;113(1):5-21. doi: 10.1002/cncr.23542. Cancer. 2008. PMID: 18473355 Free article. Review.
Bronchopulmonary neuroendocrine tumors (BP-NETs) comprise approximately 20% of all lung cancers and represent a spectrum of tumors arising from neuroendocrine cells of the BP-epithelium. Although they share structural, morphological, immunohistochemica …
Bronchopulmonary neuroendocrine tumors (BP-NETs) comprise approximately 20% of all lung cancers and represent a spectrum of tu …
Diagnostic difficulties with the diagnosis of small cell carcinoma of the lung.
Marchevsky AM, Wick MR. Marchevsky AM, et al. Semin Diagn Pathol. 2015 Nov;32(6):480-8. doi: 10.1053/j.semdp.2015.11.001. Epub 2015 Nov 10. Semin Diagn Pathol. 2015. PMID: 26597580 Review.
Small cell carcinoma of the lung (SCLC) is a well characterized form of lung cancer that is frequently already metastatic at diagnosis. ...This review discusses selected problems encountered during the pathologic diagnosis of SCLC, including its …
Small cell carcinoma of the lung (SCLC) is a well characterized form of lung cancer that is frequently already …
Large Cell Neuroendocrine Carcinoma of the Lung: Clinico-Pathologic Features, Treatment, and Outcomes.
Naidoo J, Santos-Zabala ML, Iyriboz T, Woo KM, Sima CS, Fiore JJ, Kris MG, Riely GJ, Lito P, Iqbal A, Veach S, Smith-Marrone S, Sarkaria IS, Krug LM, Rudin CM, Travis WD, Rekhtman N, Pietanza MC. Naidoo J, et al. Clin Lung Cancer. 2016 Sep;17(5):e121-e129. doi: 10.1016/j.cllc.2016.01.003. Epub 2016 Jan 21. Clin Lung Cancer. 2016. PMID: 26898325 Free PMC article.
BACKGROUND: Large cell neuroendocrine carcinoma (LCNEC) accounts for approximately 3% of lung cancers. ...Patients with stage IV LCNEC do not respond as well to platinum/etoposide compared with historic data for extensive stage small-cell …
BACKGROUND: Large cell neuroendocrine carcinoma (LCNEC) accounts for approximately 3% of lung cancers. .. …
Clinicopathological and Prognostic Significance of CD47 Expression in Lung Neuroendocrine Tumors.
Orozco-Morales M, Avilés-Salas A, Hernández-Pedro N, Catalán R, Cruz-Rico G, Colín-González AL, Dosal-Mancilla E, Barrios-Bernal P, Arrieta O. Orozco-Morales M, et al. J Immunol Res. 2021 Jun 11;2021:6632249. doi: 10.1155/2021/6632249. eCollection 2021. J Immunol Res. 2021. PMID: 34195295 Free PMC article.
BACKGROUND: Lung neuroendocrine tumors account for approximately 15% of all lung cancer cases. LNET are subdivided into typical carcinoid (TC), atypical carcinoid (AC), large cell neuroendocrine carcinoma (LCNEC), and small-cell …
BACKGROUND: Lung neuroendocrine tumors account for approximately 15% of all lung cancer cases. LNET are subdivided into …
125 results